{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:28:02Z","timestamp":1794623282086,"version":"4.9.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the extent to which internationally agreed treat-to-target recommendations were applied in clinical practice in patients with axial spondyloarthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were used from a web-based patient registry for monitoring SpA in daily practice in the Netherlands. The extent to which treat-to-target was applied was evaluated through four indicators: the proportion of patients (i) with \u22651 Ankylosing Spondylitis Disease Activity Score (ASDAS) assessed during a 1-year period, (ii) having inactive disease\/low disease activity (i.e. ASDAS\u2009&amp;lt;\u20092.1), (iii) in whom re-evaluation of ASDAS within recommended intervals occurred, and (iv) with high disease activity (HDA, i.e. ASDAS\u2009\u2265\u20092.1) in whom treatment was adapted \u22646\u2009weeks after obtaining ASDAS\u2009\u2265\u20092.1. Patients with HDA with treatment adaptations were compared with patients with HDA without treatment adaptations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 185 out of 219 patients (84%), disease activity was monitored with \u22651 ASDAS during a 1-year period, of whom 71 (38%) patients had a score below the target (ASDAS\u2009&amp;lt;\u20092.1) at first measurement. Re-evaluation of ASDAS \u22643\u2009months occurred in 11% and 23% of the patients with inactive disease\/low disease activity and HDA, respectively. Treatment adaptation occurred in 19 out of 114 patients (17%) with HDA. Patients in whom treatment was adapted had significantly higher ASDAS (P\u2009&amp;lt;\u20090.01), CRP levels (P\u2009&amp;lt;\u20090.05) and physician global assessment (P\u2009&amp;lt;\u20090.05) compared with patients without treatment adaptations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treat-to-target was applied to a limited extent in clinical practice in patients with axial spondyloarthritis. Available disease activity scores seemed not to be used for determining the frequency of re-evaluation nor treatment adaptation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab516","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T15:13:07Z","timestamp":1624633987000},"page":"1396-1407","source":"Crossref","is-referenced-by-count":13,"title":["Treat-to-target in axial spondyloarthritis: an observational study in daily practice"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-8908","authenticated-orcid":false,"given":"Esther","family":"Beckers","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center"},{"name":"Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center"},{"name":"Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-8547","authenticated-orcid":false,"given":"Casper","family":"Webers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center"},{"name":"Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2565-5439","authenticated-orcid":false,"given":"Peter","family":"ten Klooster","sequence":"additional","affiliation":[{"name":"Department of Psychology, Health & Technology, University of Twente, Enschede"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-7718","authenticated-orcid":false,"given":"Harald","family":"Vonkeman","sequence":"additional","affiliation":[{"name":"Department of Psychology, Health & Technology, University of Twente, Enschede"},{"name":"Rheumatology, Medisch Spectrum Twente, Enschede"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Efd\u00e9","sequence":"additional","affiliation":[{"name":"Rheumatology, VieCuri Medical Center, Venlo, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8477-0683","authenticated-orcid":false,"given":"Astrid","family":"van Tubergen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center"},{"name":"Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"key":"2022041112493293600_keab516-B1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","article-title":"Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study","volume":"74","author":"Ramiro","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B4","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","article-title":"High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort","volume":"75","author":"Poddubnyy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/kev267","article-title":"ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis","volume":"55","author":"van der Heijde","year":"2016","journal-title":"Rheumatology"},{"key":"2022041112493293600_keab516-B7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/annrheumdis-2019-216034","article-title":"Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis","volume":"79","author":"Kiltz","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2017-212178","article-title":"An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS","volume":"77","author":"Molto","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/BOR.0000000000000625","article-title":"Treat-to-target in axial spondyloarthritis: gold standard or fools' gold?","volume":"31","author":"Machado","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2022041112493293600_keab516-B11","first-page":"851","article-title":"Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network","volume":"33","author":"Che","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2022041112493293600_keab516-B12","first-page":"S57","article-title":"Electronic assessment of disease activity and functioning in patients with axial spondyloarthritis: challenges and unmet needs","volume":"34","author":"Kiltz","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022041112493293600_keab516-B13","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/rheumatology\/ket276","article-title":"Usability of an innovative and interactive electronic system for collection of patient-reported data in axial spondyloarthritis: comparison with the traditional paper-administered format","volume":"52","author":"Salaffi","year":"2013","journal-title":"Rheumatology"},{"key":"2022041112493293600_keab516-B14","first-page":"459","article-title":"The use of computer touch-screen technology for the collection of patient-reported outcome data in rheumatoid arthritis: comparison with standardized paper questionnaires","volume":"27","author":"Salaffi","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2022041112493293600_keab516-B15","doi-asserted-by":"crossref","first-page":"e000860","DOI":"10.1136\/rmdopen-2018-000860","article-title":"Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)","volume":"5","author":"Webers","year":"2019","journal-title":"RMD Open"},{"key":"2022041112493293600_keab516-B16","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2022041112493293600_keab516-B17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B18","first-page":"S-105","article-title":"The ASAS Health Index (ASAS HI)\u2014a new tool to assess the health status of patients with spondyloarthritis","volume":"32","author":"Kiltz","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2022041112493293600_keab516-B19","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2022041112493293600_keab516-B20","first-page":"946","article-title":"A modification of the Health Assessment Questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J Rheumatol"},{"key":"2022041112493293600_keab516-B21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical care"},{"key":"2022041112493293600_keab516-B22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-A new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"2022041112493293600_keab516-B23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/annrheumdis-2020-eular.1543","article-title":"Cluster-randomized pragmatic clinical trial evaluating the potential benefit of a tight-control and treat-to-target strategy in axial spondyloarthritis: the results of the TICOSPA trial","volume":"79","author":"Molt\u00f3","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/annrheumdis-2020-217301","article-title":"Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis","volume":"79","author":"Dures","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/jcm8091416","article-title":"Physician adherence to treat-to-target and practice guidelines in rheumatoid arthritis","volume":"8","author":"Batko","year":"2019","journal-title":"J Clin Med"},{"key":"2022041112493293600_keab516-B27","doi-asserted-by":"crossref","first-page":"e000221","DOI":"10.1136\/rmdopen-2015-000221","article-title":"When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS)","volume":"2","author":"Gvozdenovic","year":"2016","journal-title":"RMD Open"},{"key":"2022041112493293600_keab516-B28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022041112493293600_keab516-B29","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/kew303","article-title":"Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis","volume":"55","author":"Essers","year":"2016","journal-title":"Rheumatology"},{"key":"2022041112493293600_keab516-B30","article-title":"Treatment decision making among axial spondyloarthritis patients: real-world data from the ArthritisPower Registry [abstract]","volume":"72(Suppl 10","author":"Nowell","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022041112493293600_keab516-B31","doi-asserted-by":"crossref","first-page":"e000755","DOI":"10.1136\/rmdopen-2018-000755","article-title":"Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life","volume":"4","author":"Imkamp","year":"2018","journal-title":"RMD Open"},{"key":"2022041112493293600_keab516-B32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"2022041112493293600_keab516-B33","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5694\/j.1326-5377.2004.tb05948.x","article-title":"What drives change? Barriers to and incentives for achieving evidence-based practice","volume":"180","author":"Grol","year":"2004","journal-title":"Med J Aust"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab516\/41099006\/keab516.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1396\/43355990\/keab516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1396\/43355990\/keab516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T04:49:03Z","timestamp":1699159743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/4\/1396\/6310189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,6,27]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab516","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,6,27]]}}}